Lanoxin Tablet
Product Images NDC 71610-019

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lanoxin (NDC 71610-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71610 0019 60

The packaging label for LANOXIN tablets containing digoxin 0.125 mg, in a 90-tablet count. The label includes storage instructions to keep between 20-25 degrees Celsius and to keep the product out of reach of children. It is manufactured by GlaxoSmithKline and packaged by Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN 38506. The label also shows the NDC 71610-019-60 and indicates the product is for oral use and prescription only.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structural Formula (Image 01)

Chemical structure of digoxin, showing its steroid nucleus with attached lactone and sugar moieties. The diagram displays rings, hydroxyl groups, methyl groups, and other atoms typical for this cardiac glycoside.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.